HEADER HYDROLASE 13-AUG-03 1Q6M
TITLE THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH
TITLE 2 COMPOUND 3
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: CATALYTIC DOMAIN;
COMPND 5 SYNONYM: PROTEIN-TYROSINE PHOSPHATASE 1B, PTP-1B;
COMPND 6 EC: 3.1.3.48;
COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PTPN1 OR PTP1B;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFLAG-2
KEYWDS PHOSPHATASE, SECONDARY BINDING SITE, SELECTIVITY, HYDROLASE
EXPDTA X-RAY DIFFRACTION
AUTHOR G.SCAPIN,S.B.PATEL,J.W.BECKER,Q.WANG,C.DESPONTS,D.WADDLETON,K.SKOREY,
AUTHOR 2 W.CROMLISH,C.BAYLY,M.THERIEN,J.Y.GAUTHIER,C.S.LI,C.K.LAU,
AUTHOR 3 C.RAMACHANDRAN,B.P.KENNEDY,E.ASANTE-APPIAH
REVDAT 5 16-AUG-23 1Q6M 1 REMARK SEQADV
REVDAT 4 11-OCT-17 1Q6M 1 REMARK
REVDAT 3 24-FEB-09 1Q6M 1 VERSN
REVDAT 2 14-OCT-03 1Q6M 1 JRNL
REVDAT 1 30-SEP-03 1Q6M 0
JRNL AUTH G.SCAPIN,S.B.PATEL,J.W.BECKER,Q.WANG,C.DESPONTS,D.WADDLETON,
JRNL AUTH 2 K.SKOREY,W.CROMLISH,C.BAYLY,M.THERIEN,J.Y.GAUTHIER,C.S.LI,
JRNL AUTH 3 C.K.LAU,C.RAMACHANDRAN,B.P.KENNEDY,E.ASANTE-APPIAH
JRNL TITL THE STRUCTURAL BASIS FOR THE SELECTIVITY OF BENZOTRIAZOLE
JRNL TITL 2 INHIBITORS OF PTP1B
JRNL REF BIOCHEMISTRY V. 42 11451 2003
JRNL REFN ISSN 0006-2960
JRNL PMID 14516196
JRNL DOI 10.1021/BI035098J
REMARK 2
REMARK 2 RESOLUTION. 2.20 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNX
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS
REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA,
REMARK 3 : YIP,DZAKULA)
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.4
REMARK 3 NUMBER OF REFLECTIONS : 27481
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.210
REMARK 3 R VALUE (WORKING SET) : 0.210
REMARK 3 FREE R VALUE : 0.246
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1379
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 27938
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.50
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2691
REMARK 3 BIN R VALUE (WORKING SET) : 0.2790
REMARK 3 BIN FREE R VALUE : 0.3070
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 135
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2349
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 46
REMARK 3 SOLVENT ATOMS : 115
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 30.60
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.00
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -3.18000
REMARK 3 B22 (A**2) : -3.18000
REMARK 3 B33 (A**2) : 6.63030
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27
REMARK 3 ESD FROM SIGMAA (A) : 0.25
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.29
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.013
REMARK 3 BOND ANGLES (DEGREES) : 1.510
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.90
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.930
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 1.550 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.010 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 2.600 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.200 ; 2.500
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : MASK
REMARK 3 KSOL : 0.34
REMARK 3 BSOL : 32.25
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1Q6M COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-AUG-03.
REMARK 100 THE DEPOSITION ID IS D_1000019981.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 11-JUN-99
REMARK 200 TEMPERATURE (KELVIN) : 100.0
REMARK 200 PH : 7.00
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : NA
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : BRUKER
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : X-GEN
REMARK 200 DATA SCALING SOFTWARE : X-GEN
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27955
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200
REMARK 200 RESOLUTION RANGE LOW (A) : 37.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9
REMARK 200 DATA REDUNDANCY : 8.000
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.08900
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.0000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : 8.60
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.40700
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.900
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: CNX
REMARK 200 STARTING MODEL: PDB ENTRY 1Q6J
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 66.28
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.65
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, MGCL2, HEPES, PH 7.00, VAPOR
REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4
REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4
REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4
REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4
REMARK 290 7555 Y,X,-Z
REMARK 290 8555 -Y,-X,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.91450
REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.48950
REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.48950
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 34.95725
REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.48950
REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.48950
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 104.87175
REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.48950
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.48950
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 34.95725
REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.48950
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.48950
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 104.87175
REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 69.91450
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 489
REMARK 465 ASP A 490
REMARK 465 TYR A 491
REMARK 465 LYS A 492
REMARK 465 ASP A 493
REMARK 465 ASP A 494
REMARK 465 ASP A 495
REMARK 465 ASP A 496
REMARK 465 SER A 286
REMARK 465 VAL A 287
REMARK 465 GLN A 288
REMARK 465 ASP A 289
REMARK 465 GLN A 290
REMARK 465 TRP A 291
REMARK 465 LYS A 292
REMARK 465 GLU A 293
REMARK 465 LEU A 294
REMARK 465 SER A 295
REMARK 465 HIS A 296
REMARK 465 GLU A 297
REMARK 465 ASP A 298
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 497 CG CD CE NZ
REMARK 470 LEU A 498 CG CD1 CD2
REMARK 470 MET A 1 CG SD CE
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 NH1 ARG A 156 O HOH A 512 2.17
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LEU A 498 23.13 -76.29
REMARK 500 GLU A 62 -138.27 6.46
REMARK 500 LEU A 119 72.28 -111.07
REMARK 500 CYS A 121 126.31 177.01
REMARK 500 PHE A 182 13.43 57.94
REMARK 500 CYS A 215 -133.15 -142.88
REMARK 500 ILE A 219 -44.28 -134.83
REMARK 500 ILE A 261 108.76 72.51
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P27 A 301
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1Q6J RELATED DB: PDB
REMARK 900 SAME PROTEIN IN COMPLEX WITH [4-(2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-3-{
REMARK 900 4-[DIFLUORO(PHOSPHONO)METHYL]PHENYL}-2-PHENYLPROPYL)PHENYL]
REMARK 900 (DIFLUORO)METHYLPHOSPHONIC ACID
REMARK 900 RELATED ID: 1Q6N RELATED DB: PDB
REMARK 900 SAME PROTEIN IN COMPLEX WITH [{4-[(4E)-2-(1,3-BENZOTHIAZOL-2-YL)-2-
REMARK 900 (1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-EN-1-YL]PHENYL}
REMARK 900 (DIFLUORO)METHYL]PHOSPHONIC ACID
REMARK 900 RELATED ID: 1Q6P RELATED DB: PDB
REMARK 900 SAME PROTEIN IN COMPLEX WITH [{4-[(4E)-2-(1,3-BENZOTHIAZOL-2-YL)-2-
REMARK 900 (1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-EN-1-YL]PHENYL}
REMARK 900 (DIFLUORO)METHYL]PHOSPHONIC ACID
REMARK 900 RELATED ID: 1Q6S RELATED DB: PDB
REMARK 900 SAME PROTEIN IN COMPLEX WITH {6-[4-(2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-
REMARK 900 3-{4-[DIFLUORO(PHOSPHONO)METHYL]PHENYL}-2-PHENYLPROPYL)PHENYL]-2-
REMARK 900 METHYLQUINOLIN-8-YL}PHOSPHONIC ACID
REMARK 900 RELATED ID: 1Q6T RELATED DB: PDB
REMARK 900 SAME PROTEIN IN COMPLEX WITH [6-[4-(2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-
REMARK 900 3-{4-[DIFLUORO(PHOSPHONO)METHYL]PHENYL}-2-PHENYLPROPYL)PHENYL]-2-(1-
REMARK 900 METHOXY-3-METHYLBUTYL)QUINOLIN-8-YL]PHOSPHONIC ACID
DBREF 1Q6M A 1 298 UNP P18031 PTN1_HUMAN 1 298
SEQADV 1Q6M MET A 489 UNP P18031 CLONING ARTIFACT
SEQADV 1Q6M ASP A 490 UNP P18031 CLONING ARTIFACT
SEQADV 1Q6M TYR A 491 UNP P18031 CLONING ARTIFACT
SEQADV 1Q6M LYS A 492 UNP P18031 CLONING ARTIFACT
SEQADV 1Q6M ASP A 493 UNP P18031 CLONING ARTIFACT
SEQADV 1Q6M ASP A 494 UNP P18031 CLONING ARTIFACT
SEQADV 1Q6M ASP A 495 UNP P18031 CLONING ARTIFACT
SEQADV 1Q6M ASP A 496 UNP P18031 CLONING ARTIFACT
SEQADV 1Q6M LYS A 497 UNP P18031 CLONING ARTIFACT
SEQADV 1Q6M LEU A 498 UNP P18031 CLONING ARTIFACT
SEQADV 1Q6M GLU A 499 UNP P18031 CLONING ARTIFACT
SEQADV 1Q6M PHE A 500 UNP P18031 CLONING ARTIFACT
SEQRES 1 A 310 MET ASP TYR LYS ASP ASP ASP ASP LYS LEU GLU PHE MET
SEQRES 2 A 310 GLU MET GLU LYS GLU PHE GLU GLN ILE ASP LYS SER GLY
SEQRES 3 A 310 SER TRP ALA ALA ILE TYR GLN ASP ILE ARG HIS GLU ALA
SEQRES 4 A 310 SER ASP PHE PRO CYS ARG VAL ALA LYS LEU PRO LYS ASN
SEQRES 5 A 310 LYS ASN ARG ASN ARG TYR ARG ASP VAL SER PRO PHE ASP
SEQRES 6 A 310 HIS SER ARG ILE LYS LEU HIS GLN GLU ASP ASN ASP TYR
SEQRES 7 A 310 ILE ASN ALA SER LEU ILE LYS MET GLU GLU ALA GLN ARG
SEQRES 8 A 310 SER TYR ILE LEU THR GLN GLY PRO LEU PRO ASN THR CYS
SEQRES 9 A 310 GLY HIS PHE TRP GLU MET VAL TRP GLU GLN LYS SER ARG
SEQRES 10 A 310 GLY VAL VAL MET LEU ASN ARG VAL MET GLU LYS GLY SER
SEQRES 11 A 310 LEU LYS CYS ALA GLN TYR TRP PRO GLN LYS GLU GLU LYS
SEQRES 12 A 310 GLU MET ILE PHE GLU ASP THR ASN LEU LYS LEU THR LEU
SEQRES 13 A 310 ILE SER GLU ASP ILE LYS SER TYR TYR THR VAL ARG GLN
SEQRES 14 A 310 LEU GLU LEU GLU ASN LEU THR THR GLN GLU THR ARG GLU
SEQRES 15 A 310 ILE LEU HIS PHE HIS TYR THR THR TRP PRO ASP PHE GLY
SEQRES 16 A 310 VAL PRO GLU SER PRO ALA SER PHE LEU ASN PHE LEU PHE
SEQRES 17 A 310 LYS VAL ARG GLU SER GLY SER LEU SER PRO GLU HIS GLY
SEQRES 18 A 310 PRO VAL VAL VAL HIS CYS SER ALA GLY ILE GLY ARG SER
SEQRES 19 A 310 GLY THR PHE CYS LEU ALA ASP THR CYS LEU LEU LEU MET
SEQRES 20 A 310 ASP LYS ARG LYS ASP PRO SER SER VAL ASP ILE LYS LYS
SEQRES 21 A 310 VAL LEU LEU GLU MET ARG LYS PHE ARG MET GLY LEU ILE
SEQRES 22 A 310 GLN THR ALA ASP GLN LEU ARG PHE SER TYR LEU ALA VAL
SEQRES 23 A 310 ILE GLU GLY ALA LYS PHE ILE MET GLY ASP SER SER VAL
SEQRES 24 A 310 GLN ASP GLN TRP LYS GLU LEU SER HIS GLU ASP
HET P27 A 301 46
HETNAM P27 {[2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-2-(3,4-
HETNAM 2 P27 DIFLUOROPHENYL)PROPANE-1,3-DIYL]BIS[4,1-
HETNAM 3 P27 PHENYLENE(DIFLUOROMETHYLENE)]}BIS(PHOSPHONIC ACID)
FORMUL 2 P27 C29 H23 F6 N3 O6 P2
FORMUL 3 HOH *115(H2 O)
HELIX 1 1 LEU A 498 GLY A 14 1 17
HELIX 2 2 SER A 15 GLU A 26 1 12
HELIX 3 3 CYS A 32 LEU A 37 1 6
HELIX 4 4 PRO A 38 ASN A 44 5 7
HELIX 5 5 PHE A 52 HIS A 54 5 3
HELIX 6 6 THR A 91 GLN A 102 1 12
HELIX 7 7 SER A 187 SER A 201 1 15
HELIX 8 8 ILE A 219 ARG A 238 1 20
HELIX 9 9 ASP A 240 VAL A 244 5 5
HELIX 10 10 ASP A 245 LYS A 255 1 11
HELIX 11 11 THR A 263 MET A 282 1 20
SHEET 1 A 9 ARG A 56 LYS A 58 0
SHEET 2 A 9 TYR A 66 MET A 74 -1 O ALA A 69 N ILE A 57
SHEET 3 A 9 ARG A 79 THR A 84 -1 O TYR A 81 N ILE A 72
SHEET 4 A 9 VAL A 211 HIS A 214 1 O VAL A 213 N ILE A 82
SHEET 5 A 9 GLY A 106 MET A 109 1 N VAL A 108 O VAL A 212
SHEET 6 A 9 THR A 168 TYR A 176 1 O PHE A 174 N VAL A 107
SHEET 7 A 9 TYR A 153 ASN A 162 -1 N ARG A 156 O HIS A 173
SHEET 8 A 9 LEU A 140 ILE A 149 -1 N ASP A 148 O VAL A 155
SHEET 9 A 9 MET A 133 PHE A 135 -1 N PHE A 135 O LEU A 140
SITE 1 AC1 27 ALA A 18 ASP A 22 HIS A 25 GLU A 26
SITE 2 AC1 27 TYR A 46 ARG A 47 ASP A 48 VAL A 49
SITE 3 AC1 27 SER A 118 LEU A 119 ASP A 181 PHE A 182
SITE 4 AC1 27 CYS A 215 SER A 216 ALA A 217 GLY A 218
SITE 5 AC1 27 ILE A 219 GLY A 220 ARG A 221 MET A 258
SITE 6 AC1 27 GLY A 259 GLN A 262 HOH A 521 HOH A 546
SITE 7 AC1 27 HOH A 552 HOH A 560 HOH A 608
CRYST1 86.979 86.979 139.829 90.00 90.00 90.00 P 41 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011497 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011497 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007152 0.00000